Home › Acute Lymphoblastic Leukemia › New York
Acute Lymphoblastic Leukemia clinical trials in New York
32 studies for Acute Lymphoblastic Leukemia are looking for participants at sites in New York.
Cities in New York
- New York City24 studies
- Queens6 studies
- The Bronx5 studies
- Buffalo4 studies
- Rochester4 studies
- Greenburgh4 studies
- Staten Island3 studies
- New Rochelle3 studies
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Queens Hospital Center, Jamaica
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Stony Brook University Medical Center, Stony Brook
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1
Ages 12 to 78 · All sexes · Updated Sep 29, 2026 · NCT03802695A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- Memorial Sloan Kettering Cancer Center -- Pediatrics, New York
RecruitingPhase 2
6 Months · All sexes · Updated Sep 28, 2026 · NCT06514794Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children
- Columbia University Medical Center, New York
RecruitingObservational study
4 Weeks – 18 Years · All sexes · Updated Sep 24, 2026 · NCT06529575Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
- Montefiore Einstein Comprehensive Cancer Center, The Bronx
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT06308588A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Montefiore Medical Center, New York
RecruitingPhase 1/2
30 Days · All sexes · Updated Sep 16, 2026 · NCT04065399A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
- The Mount Sinai Hospital, New York
RecruitingPhase 1
Ages 0 to 18 · All sexes · Updated Sep 16, 2026 · NCT06173518Cord Blood Transplant in Adults With Blood Cancers
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 2
Ages 21 to 65 · All sexes · Updated Sep 11, 2026 · NCT05884333First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 1, 2026 · NCT07586618The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Albany Medical Center, Albany
- Maimonides Medical Center, Brooklyn
- NYU Langone Hospital - Long Island, Mineola
- and 7 more
RecruitingPhase 1/2
Up to age 22 · All sexes · Updated Aug 25, 2026 · NCT04726241A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia
- Memorial Sloan Kettering Cancer Commack - Suffolk (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- and 1 more
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Aug 20, 2026 · NCT07400029A Study of CTD402 in T-ALL/LBL Patients
- Memorial Sloan Kettering Cancer Center, New York
- Montefiore Einstein Comprehensive Cancer Center, The Bronx
RecruitingPhase 1/2
Ages 1 and older · All sexes · Updated Aug 19, 2026 · NCT07070219MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence
- Roswell Park Cancer Institute, Buffalo
RecruitingHealthy volunteers welcome
All ages · All sexes · Updated Aug 12, 2026 · NCT06323044Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Research Site, New York
RecruitingPhase 1/2
Ages 16 and older · All sexes · Updated Jul 20, 2026 · NCT07155226A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Roswell Park Cancer Institute, Buffalo
- North Shore University Hospital, Lake Sucess
- Cohen Children's Medical Center of New York, New Hyde
- and 9 more
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545A Study of Revumenib and Mezigdomide in People With Leukemia
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- and 1 more
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Jun 22, 2026 · NCT07356154TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1/2
Up to age 1 · All sexes · Updated Jun 3, 2026 · NCT05848687European Prospective Investigation Into Childhood Cancer
- Columbia University Irving Medical Center, New York
RecruitingObservational study
Ages 3 to 21 · All sexes · Updated Jun 2, 2026 · NCT05375617Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
- University of Rochester, Rochester
- Stony Brook University Medical Center, Stony Brook
- and 1 more
RecruitingObservational study
All ages · All sexes · Updated May 18, 2026 · NCT01790152Cord Blood Transplantation in Children and Young Adults With Blood Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
RecruitingPhase 2
Up to age 26 · All sexes · Updated May 14, 2026 · NCT07566377A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
- Ascentage Investigative Site #1160, Stony Brook
- Ascentage Investigative Site #1151, The Bronx
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Apr 30, 2026 · NCT06051409Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
- Roswell Park Comprehensive Cancer Center, Buffalo
Recruiting
Ages 3 to 9 · All sexes · Updated Apr 23, 2026 · NCT06074666Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD)
- The Mt. Hope Family Center, Rochester
Recruiting
Ages 8 to 17 · All sexes · Updated Apr 8, 2026 · NCT06956781A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Roswell Park Comprehensive Cancer Center, Buffalo
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Mar 24, 2026 · NCT04988555A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)
- University of Rochester Medical Center, Wilmot Cancer Center, Rochester
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Mar 18, 2026 · NCT06207123A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- Memorial Sloan Kettering, New York
RecruitingPhase 2
Ages 18 to 66 · All sexes · Updated Mar 17, 2026 · NCT06859424Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 2
Ages 18 to 54 · All sexes · Updated Mar 17, 2026 · NCT06918431A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)
- Memorial Sloan Kettering Cancer Suffolk-Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- and 1 more
RecruitingPhase 1
Ages 17 and older · All sexes · Updated Feb 10, 2026 · NCT06287528Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1
Ages 12 and older · All sexes · Updated Jan 8, 2026 · NCT04872478A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk Factors
- Columbia University Medical Center, New York
Recruiting
Ages 5 to 21 · All sexes · Updated Oct 7, 2025 · NCT05963971Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Apr 15, 2025 · NCT06462365Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Children's Hospital New York-Presbyterian, New York
- Memorial Sloan Kettering Cancer Center, New York
RecruitingPhase 1
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.